老虎证券

BRIEF-Adagio Medical To List On Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV

Reuters
2024/02/14

Feb 14 (Reuters) - ARYA Sciences Acquisition Corp IV

:

* ADAGIO MEDICAL TO LIST ON NASDAQ THROUGH BUSINESS COMBINATION WITH ARYA SCIENCES ACQUISITION CORP IV, ENABLING FURTHER COMMERCIAL AND CLINICAL DEVELOPMENT OF INNOVATIVE CARDIAC ABLATION TECHNOLOGIES

* ARYA SCIENCES ACQUISITION CORP IV - TRANSACTION IMPLIES A POST-TRANSACTION FULLY DILUTED EQUITY VALUE OF COMBINED COMPANY OF $128 MILLION

* ARYA SCIENCES ACQUISITION CORP IV: COMBINED CO EXPECTS TO RECEIVE ABOUT $42 MILLION FROM EQUITY AND CONVERTIBLE NOTE INVESTORS AT CLOSING

* ARYA SCIENCES ACQUISITION CORP IV - TRANSACTION IMPLIES A POST-TRANSACTION FULLY DILUTED ENTERPRISE VALUE OF $113 MILLION OF COMBINED CO

* ARYA SCIENCES ACQUISITION CORP IV: INC." COMBINED CO'S COMMON STOCK EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL "ADGM"

* ARYA SCIENCES ACQUISITION CORP IV - CURRENT INVESTORS IN ADAGIO MEDICAL ARE EXPECTED TO OWN ABOUT 10.2% OF COMBINED CO

* ARYA SCIENCES ACQUISITION CORP IV - PERCEPTIVE AND ARYA SCIENCES HOLDINGS IV COLLECTIVELY, ARE EXPECTED TO HOLD ABOUT 58.2% OF COMBINED CO

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10